JAK2 V617F mutation
<p>Analysis of the reannealing- instead of melting-curve in the detection of JAK2 V617F mutation by HRM method</p>
... cells. JAK2 mutation, called JAK2 V617F, is frequently found in Philadelphia chromosome-negative myeloproliferative ...for JAK2 V617F mutation ...for JAK2 ...
7
Secondary Acute Myeloid Leukemia in a One-Year-Old Girl Diagnosed with JAK2-V617F Mutation Positive Myeloproliferative Neoplasm
... The JAK2-V617F mutation result did not alter her clinical course as she would have been upstaged to high risk due to her MRD status, but it does explain her poor response to ...
5
The JAK2 V617F Mutation in Chronic Myeloid Leukaemia within a BCR-ABL Positive Cohort of Beninese Patients
... the JAK2 V617F mutation by ARMS PCR using the four pairs of primers was ...the JAK2 gene. They did not have a 279 bp band, which is the size of the JAK2 V617F ...
6
Original Article Chronic neutrophilic leukemia with JAK2 V617F mutation: a case report
... JAK2 V617F targets different types of cells and hence leads to different ...the JAK2 V617F-targeted cells might be ...the JAK2 V617F-targeted progenitor cells differentiated into ...
6
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
... with JAK2 V617F mutation who developed 4 different neoplastic processes: adenocar- cinoma of the lung, MPN/CMML, diffuse large B-cell lymphoma (DLBCL), acute myeloid leukemia with mono- cytic ...
5
“Study of JAK2 V617F mutation, serum B12 level and interleukin – 23 level in polycythemia vera
... for JAK2 V617F mutation analysis. From 48 JAK2 +ve mutation patients, 30 cases were selected who met the diagnostic criteria of PV according to: questionnaire that included their ...
8
Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms – long term follow-up of a regional case series
... preclude JAK2 V617F testing ...of JAK2 V617F appears to function as an all or nothing ef- fect with JAK2 V617F allele burden previously observed to be low in this patient group ...
7
A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation
... the V617F mutation was present in granulocytes and in hematopoietic stem and progenitor cells (HSPCs), but not in the CD34 + CD19 + population that mostly consists of Ph + ALL cells, indicating that this Ph ...
5
JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit)
... This case report focuses on a 71-year old patient affected by unknown dyspnea and erythrocytosis referred by his general practitioner to our center for specialist advice after a hema- tological examination had excluded ...
5
The Prevalence of JAK2 -V617F Mutation in Sudanese Patients with Chronic Myeloproliferative Neoplasms
... of JAK2-V617F mutation in 2005 [6,7], the mutation results from a somatic G to T mutation involving JAK2 exon 14, which leads to nucleotide change at position 1849 and the ...
7
Original Article Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients
... ity of ARMS technique was found to be 1% to 2%. Two primer pairs used to specifically ampli- fy the normal and mutant sequences plus a positive control band in a single reaction. PCR primers were: forward outer (FO), ...
5
Evaluation of the JAK2 Gene Mutation in Moroccan Patients with Chronic Myeloproliferative Disorders
... of mutation was associated with higher levels of WBC and ...positive JAK2-V617F mutation have relation with higher WBC ...positive JAK2-V617F ...
8
Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation
... the JAK2 gene of about 1147 bp was ...the JAK2 V617F mutation with the guanine to thymine substitution at nucleotide 1849 in exon 14 of the JAK2 ...
7
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis
... In January 2011, a 64-year-old man was referred to our Department with leukocytosis (WBC 20.100/uL with 71.8 % neutrophils), macrocytic anemia (Hb 11,5 g/dL; MCV 104 fl), splenomegaly, and hepatomegaly. Bone mar- row ...
6
Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis
... The JAK2 V617F mutation, which leads to constitutive JAK2 activation, was shown to play an important role in MPN pathogenesis, and is found in 95% of Polycythemia Vera (PV) patients and in at ...
11
Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms
... [1–3]. JAK2, a member of the JAK family (JAK1, JAK2, JAK3, and Tyk2), is crucial for signal transduction downstream of the acti- vation of erythropoietin, thrombopoietin and other related receptors which ...
12
Impact of <em>JAK2</em>(<em>V617F</em>) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study
... n=22; JAK2-negative, ...in JAK2-positive (85.7%, n=12) versus JAK2-negative patients ...of JAK2-positive and 66.7% (n=16/24) of JAK2-negative patients achieving at least a partial ...
8
Myelodysplastic disorders carrying both isolated del(5q) and <em>JAK2<sup>V617F</sup></em> mutation: concise review, with focus on lenalidomide therapy
... tion is a rare event which occurs prevalently in patients with a possibly “mixed” and still not well-defined MDS/MPN disorder. However, it would seem possible to identify some cases characterized by peculiar cytogenetic, ...
8
DETECTION OF JAK2 MUTATION IN CASES OF MYELODYSPLASTIC SYNDROME
... gain-of-function mutation in exon 14 that results from a guanine- to-thymine transversion at nucleotide 1849 with substitution of valine to phenylalanine at codon ...of JAK2 mutation in cases of MDS ...
8
JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients
... the JAK2 exon 12, 13 and 14 were carried out on all 78 CMPN ...revealed JAK2 V617F mutation in 10 PV cases (91%), 4 ET cases (40%), 3 MF cases (25%) and none CML cases ...reported JAK2 ...
5